Octerloney B. McDonald
GlaxoSmithKline (United Kingdom)(GB)
Publications by Year
Research Areas
Protein Kinase Regulation and GTPase Signaling, Quinazolinone synthesis and applications, Synthesis and biological activity, Microtubule and mitosis dynamics, HER2/EGFR in Cancer Research
Most-Cited Works
- → A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)(2004)1,108 cited
- → The discovery of potent cRaf1 kinase inhibitors(2000)205 cited
- → Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase(2010)109 cited
- → Heterogeneity of contractile proteins. A continuum of troponin-tropomyosin expression in mammalian skeletal muscle.(1985)84 cited
- → Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors(2008)83 cited
- → A Scintillation Proximity Assay for the Raf/MEK/ERK Kinase Cascade: High-Throughput Screening and Identification of Selective Enzyme Inhibitors(1999)69 cited
- → Activation of casein kinase II by sphingosine.(1991)69 cited
- → Discovery of Selective Small Molecule Type III Phosphatidylinositol 4-Kinase Alpha (PI4KIIIα) Inhibitors as Anti Hepatitis C (HCV) Agents(2013)67 cited
- → Phosphorylation of a Ras-related GTP-binding protein, Rap-1b, by a neuronal Ca2+/calmodulin-dependent protein kinase, CaM kinase Gr.(1991)61 cited
- → Biochemical characterization of GSK1070916, a potent and selective inhibitor of Aurora B and Aurora C kinases with an extremely long residence time1(2009)56 cited